Universal admission laboratory screening for severe acute respiratory coronavirus virus 2 (SARS-CoV-2) asymptomatic infection across a large health system.
Jennifer L CihlarBryan D HarrisPatty W WrightRomney M HumphriesCaroline K TaylorBrandi R CherryThomas R TalbotPublished in: Infection control and hospital epidemiology (2022)
Implementing an asymptomatic patient admission testing program can provide clinically relevant data based on the NNT, even during periods of lower transmission and among different patient populations. Limiting admission testing to non-fully vaccinated patients during periods of lower transmission may be a strategy to address resource concerns around this practice. Although the impact of such testing on healthcare-associated COVID-19 among patients and healthcare workers could not be clearly determined, these data provide important information as facilities weigh the costs and benefits of such testing.
Keyphrases
- sars cov
- healthcare
- emergency department
- quality improvement
- end stage renal disease
- respiratory syndrome coronavirus
- coronavirus disease
- ejection fraction
- electronic health record
- newly diagnosed
- chronic kidney disease
- primary care
- big data
- prognostic factors
- machine learning
- health information
- peritoneal dialysis
- data analysis
- deep learning